Angel Biotechnology Holdings PLC
|
44 Colbourne Crescent
Nelson Park Industrial Estate
Cramlington NE23 1WB
United Kingdom |
| Tel: |
44/ 1670 591920 |
| URL: |
http://www.angelbio.com |
|
 |
| Primary Symbols & Exchanges: |
| ABH - London |
|
|
| Primary Industry: |
| Biotechnology |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activity is manufacturing and supplying clinical grade materials for use in drug development work. The Group supplies the biopharmaceutical contract manufacturing sector of the biologics market and within that sector is focusing on the early stage drug development work such as CMC and pre-clinical studies, along with drug products for Phase I, II and III of clinical trials. The Group has expertise in the manufacture and development of recombinant proteins, cellular therapies and stem cells, antibodies, and viruses. The Group operates predominantly in the United Kingdom. During 2006, the Group acquired the entire share capital of Angel Biotechnology Ltd. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Angel Biotechnology Holdings PLC
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
